Atlas Trials

Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer

Clinical trial NCT00806650 · COMPLETED

Trial details

NCT number
NCT00806650
Sponsor
City of Hope Medical Center
Status
COMPLETED
Study type
OBSERVATIONAL
Kidney Cancer
Start date
2008-07-01
Primary completion
2017-11-15
Enrollment
155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.